Current Diabetes Reports

The new diabetes inhalers: New tools for the clinician

William T. Cefalu

Web alert

ADOPT: Lessons from Comparison of Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Hannele Yki-Jarvinen

NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes

Elisabetta Bugianesi, Ester Vanni, Giulio Marchesini

Nonalcoholic fatty liver disease and cardiovascular disease risk

Roger K. Schindhelm, Michaela Diamant, Robert J. Heine

Antihypertensive agents, insulin sensitivity, and new-onset diabetes

Pantelis A. Sarafidis, Samy I. McFarlane, George L. Bakris

Prevention of type 2 diabetes: An update

Amal Farag, Jocelyne Karam, John Nicasio, Samy I. McFarlane

Hypertension in people with diabetes and the metabolic syndrome: Pathophysiologic insights and therapeutic update

Sudha Ganne, Surender K. Arora, Olena Dotsenko, Samy I. McFarlane, Adam Whaley-Connell

Pioglitazone and Nonalcoholic Steatohepatitis

Guenther Boden

Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation

Guenther Boden, A. Koneti Rao

Dyslipidemia in type 2 diabetes mellitus

Ramprasad Gadi, Frederick F. Samaha

Glycotoxins in the diet promote diabetes and diabetic complications

Helen Vlassara, Gary Striker

Inflammatory mechanisms of diabetic complications

Michael D. Williams, Jerry L. Nadler